SGS unveils RSV A-strain challenge agent for vaccine research
SGS has launched a novel Respiratory Syncytial Virus (RSV) A-strain challenge agent designed to accelerate clinical validation of RSV vaccines and therapeutics through controlled human infection models (CHIM).













